CHOP doctors find access to GLP-1 drugs for childhood obesity remains limited
More from Philadelphia, Pennsylvania, United States →
Out-of-pocket costs, insurance coverage, side effects and a lack of long-term safety data can be barriers to medication for childhood obesity.
Open original source
No comments yet.